XML 26 R8.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net income $ 349.9 $ 341.2
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 69.1 81.2
Amortization of debt issuance cost and debt discount 1.2 1.3
Loss on settlement of contingent consideration 3.0  
Unrealized gain on available-for-sale financial investments (0.9) (1.6)
Provision for accounts receivable credit losses 1.6 1.8
Benefit for deferred income taxes (21.2) (17.3)
Stock-based compensation expense 22.0 26.0
Impairment of intangible assets 81.0  
Impairment of minority investment 16.0  
Impairment of property and equipment 0.3  
Gain from Cboe Digital non-recourse notes and warrants wind down (2.4)  
Gain on sale of property held for sale (1.0)  
Gain on lease termination (0.7)  
Expenses from Cboe Digital wind down 0.8  
Pyth tokens revenue (1.0)  
Equity earnings on investments (26.5) (22.9)
Changes in assets and liabilities:    
Accounts receivable (44.2) 12.6
Restricted cash and cash equivalents and customer bank deposits (included in margin deposits, clearing funds, and interoperability funds) 1,923.2 168.8
Income taxes receivable 39.6 10.3
Other current assets 5.2 (4.7)
Other assets (12.9) (17.2)
Accounts payable and accrued liabilities (113.3) (36.8)
Section 31 fees payable 68.7 (37.3)
Deferred revenue 4.0 2.8
Income taxes payable (1.0) (3.6)
Unrecognized tax benefits 27.1 27.6
Other liabilities 1.9 (4.5)
Net cash provided by operating activities 2,389.5 527.7
Cash flows from investing activities:    
Purchases of available-for-sale financial investments (46.3) (69.7)
Proceeds from maturities of available-for-sale financial investments 20.6 64.4
Proceeds from sale of intangible assets   0.8
Proceeds from sale of property held for sale 3.3  
Proceeds from sale of property and equipment 0.7  
Proceeds from insurance 0.1  
Contributions to investments (3.7) (18.1)
Purchases of property and equipment and leasehold improvements (25.1) (20.2)
Net cash used in investing activities (50.4) (42.8)
Cash flows used in financing activities:    
Principal payments of current portion of long-term debt   (140.0)
Cash dividends on common stock (116.7) (106.5)
Repurchases of common stock from employee stock plans (27.2) (13.0)
Payments of contingent consideration related to acquisitions (13.0) (10.2)
Shares issued under employee stock purchase plan (5.4) (0.9)
Payments for Cboe Digital non-recourse notes and warrants wind down (6.0)  
Purchase of common stock (177.9) (78.1)
Net cash used in financing activities (346.2) (348.7)
Effect of foreign currency exchange rates on cash, cash equivalents, and restricted cash and cash equivalents (41.4) 20.3
Increase in cash, cash equivalents, and restricted cash and cash equivalents 1,951.5 156.5
Beginning of period 1,397.1 979.9
End of period 3,348.6 1,136.4
Supplemental disclosure of cash transactions:    
Cash paid for income taxes, net of refunds 178.3 129.5
Cash paid for interest 62.4 $ 38.4
Supplemental disclosure of noncash investing activities:    
Note receivable from sale of property held for sale 6.4  
Additions of intangible assets 1.0  
Supplemental disclosure of noncash financing activities:    
Unsettled purchases of common stock (1.8)  
Cboe Digital non-recourse notes and warrants asset 16.2  
Cboe Digital non-recourse notes and warrants liability $ (16.2)